Caspase-3 and Tissue Factor Expression in Lipid-Rich Plaque Macrophages: Evidence for Apoptosis as Link between Inflammation and Atherothrombosis

Circulation

Volumn 109, Issue 16, 2004, Pages 2001-2008

  Hutter, Randolph ^a   Valdiviezo, Carolina ^a   Sauter, Bernhard V ^a   Savontaus, Mikko ^a   Chereshnev, Igor ^a   Carrick, Francine E ^a   Bauriedel, Gerhard ^b   Lüderitz, Berndt ^b   Fallon, John T ^a   Fuster, Valentin ^a,c   Badimon, Juan J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Cardiovascular Institute   (United States)

Author keywords

Apoptosis; Inflammation; Lipids; Thrombosis

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CELL ACTIVATION; CELL TYPE; CELL VIABILITY; CLINICAL PATHWAY; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; LIPID COMPOSITION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; THROMBOGENESIS; THROMBOSIS;

ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; CASPASE 3; CASPASES; FOAM CELLS; GENE EXPRESSION; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; THROMBOPLASTIN; THROMBOSIS;

EID: 11144354379     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000125526.91945.AE     Document Type: Article

References (24)

1. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992;326:242-250.
2. Breslow JL. Mouse models of atherosclerosis. Science. 1996;272:685-688.
3. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 1989; 86:1372-1376.
4. Parthasarathy S, Quinn MT, Schwenke DC, et al. Oxidative modification of beta-very low density lipoprotein: potential role in monocyte recruitment and foam cell formation. Arteriosclerosis. 1989;9:398-404.
5. Konigsberg W, Kirchhofer D, Riederer MA, et al. The TF:VIIa complex: clinical significance, struction-function relationships and its role in signaling and metastasis. Thromb Haemost. 2001;86:757-771.
6. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 1996; 94:3090-3097.
7. Fernandez-Ortiz A, Badimon JJ, Falk E, et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994;23:1562-1569.
8. Badimon JJ, Lettino M, Toschi V, et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation. 1999;99:1780-1787.
9. Toschi V, Gallo R, Lettino M, et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997;95:594-599.
10. Hegyi L, Skepper IN, Cary NR, et al. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol. 1996;180: 423-429.
11. Bauriedel G, Hutter R, Welsch U, et al. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res. 1999;41:480-488.
12. Casciola-Rosen L, Rosen A, Petri M, et al. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA. 1996;93:1624-1629.
13. Mallat Z, Hugel B, Ohan I, et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation. 1999;99:348-353.
14. Reis ED, Roque M, Dansky H, et al. Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice. Proc Natl Acad Sci USA. 2000;97:12764-12769.
15. Dominaitiene RLS, Janciauskiene S. Effects of differently oxidized LDL on the expression of pro-inflammatory molecules in human monocytes in vitro. In Vitro Mol Toxicol. 2001;14:83-97.
16. Thiruvikraman SV, Guha A, Roboz J, et al. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest. 1996;75:451-461.
17. Bauriedel G, Schluckebier S, Hutter R, et al. Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol. 1998;18:1132-1139.
18. St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science. 2000;289:1197-1202.
19. Kockx MM, Herman AG. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res. 2000;45:736-746.
20. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377-381.
21. Lu B, Wang L, Medan D, et al. Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages. Am J Physiol. 2002;283:C831-C838.
22. Schecter AD, Giesen PL, Taby O, et al. Tissue factor expression in human arterial smooth muscle cells: TF is present in three cellular pools after growth factor stimulation. J Clin Invest. 1997;100:2276-2285.
23. Mallat Z, Ohan J, Leseche G, et al. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 1997;96:424-425.
24. Kolodgie FD, Narula J, Burke AP, et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol. 2000;157:1259-1268.